Secondary diabetes is hyperglycemia caused by another identifiable condition — including pancreatic disease, endocrine disorders, certain medications, genetic syndromes, and infections — rather than primary autoimmunity or insulin resistance. Identifying and treating the underlying cause can sometimes reverse or substantially improve the diabetes.
What Counts as Secondary Diabetes?
The American Diabetes Association classifies diabetes into four broad categories — type 1, type 2, gestational, and “other specific types.” Secondary diabetes falls into the “other specific types” category and is defined by an identifiable underlying cause that drives hyperglycemia.
Major Categories of Secondary Diabetes
| Category | Examples |
|---|---|
| Pancreatic disease (type 3c) | Chronic pancreatitis, pancreatic surgery, pancreatic cancer, cystic fibrosis, hemochromatosis |
| Endocrine disorders | Cushing’s syndrome, acromegaly, pheochromocytoma, hyperthyroidism, glucagonoma, somatostatinoma, aldosteronoma |
| Drug-induced | Glucocorticoids, atypical antipsychotics, immunosuppressants, antiretrovirals, thiazides, beta-blockers, statins (minor) |
| Genetic syndromes | Down syndrome, Turner syndrome, Klinefelter syndrome, Prader-Willi syndrome, Wolfram syndrome, Friedreich ataxia, lipodystrophy syndromes |
| Infections | Congenital rubella, cytomegalovirus, Coxsackie B (suspected) |
| Immune-mediated rare forms | Anti-insulin receptor antibodies (type B insulin resistance), Stiff-person syndrome |
Pancreatic Causes (Type 3c)
Damage to the pancreas reduces both insulin (beta-cell) and glucagon (alpha-cell) output. Chronic pancreatitis accounts for the majority of cases. Pancreatic surgery, cancer, cystic fibrosis, and hemochromatosis (iron deposition in the pancreas) are also causes. See our dedicated guide on type 3c pancreatogenic diabetes for detail.
Endocrine Causes
Cushing’s Syndrome
Endogenous excess cortisol — from a pituitary adenoma (Cushing’s disease), adrenal tumor, or ectopic ACTH source — increases hepatic gluconeogenesis, decreases insulin sensitivity, and reduces beta-cell function. Roughly 30 to 60 percent of patients develop diabetes or prediabetes. See our companion article on Cushing’s-induced diabetes.
Acromegaly
- Caused by growth hormone excess from a pituitary adenoma
- GH and IGF-1 antagonize insulin action
- 10 to 30 percent of patients develop diabetes
- Surgery or somatostatin analogs (octreotide, lanreotide) may improve glucose
Pheochromocytoma
- Adrenal medullary tumor secreting catecholamines
- Epinephrine and norepinephrine suppress insulin secretion and increase gluconeogenesis
- Hypertension is the classic presentation; diabetes may be intermittent
- Tumor removal often reverses the diabetes
Hyperthyroidism
- Thyroid hormone excess accelerates carbohydrate absorption and hepatic glucose output
- Mild hyperglycemia, especially postprandial
- Resolves with treatment of hyperthyroidism
Glucagonoma and Somatostatinoma
- Rare pancreatic islet tumors
- Glucagonoma — excess glucagon raises glucose; characteristic necrolytic migratory erythema rash
- Somatostatinoma — excess somatostatin inhibits insulin (and many other hormones)
Drug-Induced Diabetes
| Drug Class | Mechanism | Reversibility |
|---|---|---|
| Glucocorticoids | Increase gluconeogenesis, reduce insulin sensitivity | Often reversible with taper |
| Atypical antipsychotics (olanzapine, clozapine) | Weight gain, direct beta-cell effects | Variable |
| Calcineurin inhibitors (tacrolimus, cyclosporine) | Direct beta-cell toxicity | May persist after transplant |
| Protease inhibitors (HIV therapy) | Insulin resistance, lipodystrophy | May improve with regimen switch |
| Thiazide diuretics | Hypokalemia, reduced insulin secretion | Dose-dependent, partial reversibility |
| Beta-blockers (non-selective) | Masked hypoglycemia symptoms, mild insulin effects | Variable |
| Statins | Small increase in diabetes incidence — usually outweighed by cardiovascular benefit | Not typically discontinued for this reason |
| Niacin (high-dose) | Insulin resistance | Reversible |
| Pentamidine | Beta-cell destruction | Often permanent |
| Diazoxide | Blocks insulin release | Reversible |
For more on the most common drug class, see our steroid-induced diabetes guide.
Genetic Syndromes
- Down syndrome — increased risk of type 1 diabetes; also some metabolic features
- Turner syndrome — insulin resistance and glucose intolerance more common
- Klinefelter syndrome — insulin resistance
- Prader-Willi syndrome — early obesity and high diabetes risk in adolescence
- Wolfram syndrome (DIDMOAD) — diabetes insipidus, diabetes mellitus, optic atrophy, deafness
- Friedreich ataxia — neurodegenerative disorder with diabetes in 10 to 30 percent
- Lipodystrophy syndromes — severe insulin resistance from absent or dysfunctional adipose tissue
Infectious Causes
- Congenital rubella — direct beta-cell infection; ~20 percent develop diabetes
- Cytomegalovirus — beta-cell infection in immunocompromised hosts
- Coxsackie B and other enteroviruses — proposed trigger for autoimmune diabetes; not strictly “secondary”
Symptoms
Glucose-related symptoms are similar to type 1 and type 2 diabetes — thirst, urination, fatigue, weight changes, blurred vision, slow healing. The presence of features specific to the underlying cause is the diagnostic clue:
- Central obesity, moon face, striae, easy bruising — Cushing’s syndrome
- Coarsening facial features, large hands and feet, deep voice — acromegaly
- Episodic hypertension, palpitations, sweating — pheochromocytoma
- Tremor, weight loss, heat intolerance — hyperthyroidism
- Necrolytic migratory erythema — glucagonoma
- Chronic abdominal pain, steatorrhea — chronic pancreatitis
- Recent steroid course or psychiatric medication change — drug-induced
Diagnosis
Confirming Diabetes
- Standard criteria — fasting glucose ≥126 mg/dL, A1C ≥6.5 percent, OGTT 2-hour ≥200 mg/dL, or random glucose ≥200 with symptoms — see our A1C levels guide
- Negative islet autoantibodies — argues against type 1 diabetes
- C-peptide — usually preserved unless beta-cell function is impaired
Identifying the Cause
- Medication review — every drug including over-the-counter
- Cortisol testing (24-hour urine, late-night salivary, dexamethasone suppression) — Cushing’s
- IGF-1 and growth hormone suppression test — acromegaly
- Plasma or urine metanephrines — pheochromocytoma
- TSH and free T4 — hyperthyroidism
- Pancreatic imaging (CT or MRI) — pancreatic disease
- Stool elastase — exocrine insufficiency
- Genetic testing in syndromic presentations
Treatment
Treating the Underlying Cause
- Surgical resection — adrenal adenoma, pituitary adenoma, pheochromocytoma, glucagonoma
- Medical therapy — somatostatin analogs (acromegaly), pasireotide or metyrapone (Cushing’s), antithyroid drugs
- Medication taper — glucocorticoids, when clinically feasible
- Pancreatic enzyme replacement — exocrine insufficiency
- Iron removal — hemochromatosis
Glucose Management
- Lifestyle measures — physical activity, dietary modification (see diet and nutrition)
- Metformin — first-line for most insulin-resistant forms
- Insulin — for type 3c or severe steroid-induced diabetes
- SGLT2 inhibitors — caution in volume-depleted or ketotic-prone states
- GLP-1 receptor agonists — may be useful in steroid- or antipsychotic-related hyperglycemia
Reversibility by Cause
| Cause | Reversibility Potential |
|---|---|
| Short-course glucocorticoids | Usually reversible |
| Cushing’s syndrome (surgically cured) | Often partial or complete reversibility |
| Acromegaly (controlled) | Usually improves |
| Pheochromocytoma (resected) | Often resolves |
| Hyperthyroidism (treated) | Usually resolves |
| Chronic pancreatitis | Permanent |
| Post-pancreatectomy | Permanent |
| Genetic syndromes | Permanent |
| Antipsychotic-associated | May improve with regimen change |
For a broader discussion of remission concepts in diabetes, see is prediabetes reversible?.
Prevention
- Use glucocorticoids and other diabetogenic medications at the lowest effective dose for the shortest time
- Screen high-risk populations (HIV on protease inhibitors, transplant recipients, long-term steroid users) regularly
- Identify and treat endocrine disorders early
- Limit alcohol to reduce chronic pancreatitis risk
- Genetic counseling and screening in families with relevant syndromes
Related Reading
See our companion guides on type 3c pancreatogenic diabetes, steroid-induced diabetes, Cushing’s-induced diabetes, cystic fibrosis-related diabetes, and the prediabetes basics hub.
The Bottom Line
Secondary diabetes is the umbrella term for diabetes caused by an identifiable underlying condition — pancreatic disease, endocrine excess, medications, genetic syndromes, or infections. Correct attribution is important because treating the cause sometimes reverses or substantially improves the diabetes. Drug-induced and surgically curable endocrine forms have the best reversibility; pancreatic and genetic forms are usually permanent but still benefit from treating the underlying condition. Workup includes hormone testing, imaging, medication review, and sometimes genetic testing. Talk to your doctor or an endocrinologist if your diabetes does not fit a typical type 1 or type 2 pattern.
